WETS
TMCI icon

Wealth Enhancement Trust Services’s Treace Medical Concepts TMCI Stock Holding History

Wealth Enhancement Trust Services’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$724 Buy
+182
New +$500 ﹤0.01% 1187

Other funds holding TMCI

GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AWMNY
Arcadia Wealth Management (New York) Smithtown, New York $210M AUM 25.07% 1-Year Est. Return

Wealth Enhancement Trust Services's TMCI Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in Treace Medical Concepts (TMCI) in Q2 2026: 182 shares worth $724. The stake represents ﹤0.01% of the portfolio and ranks #1187 among its holdings.

67 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Wealth Enhancement Trust Services held 182 shares of Treace Medical Concepts worth $724 as of Q2 2026.
  • Treace Medical Concepts was a new Wealth Enhancement Trust Services position in Q2 2026.
  • Treace Medical Concepts made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #1187 holding.
  • 67 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.